Christina M. Ackermann
2017
In 2017, Christina M. Ackermann earned a total compensation of $2.8M as Executive Vice President and General Counsel at Valeant Pharmaceuticals International, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $636,000 |
|---|---|
| Option Awards | $360,006 |
| Salary | $600,000 |
| Stock Awards | $906,030 |
| Other | $293,116 |
| Total | $2,795,152 |
Ackermann received $906K in stock awards, accounting for 32% of the total pay in 2017.
Ackermann also received $636K in non-equity incentive plan, $360K in option awards, $600K in salary and $293.1K in other compensation.
Rankings
In 2017, Christina M. Ackermann's compensation ranked 3,923rd out of 14,666 executives tracked by ExecPay. In other words, Ackermann earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,923 out of 14,666 | 73rd |
Division Manufacturing | 1,372 out of 5,772 | 76th |
Major group Chemicals And Allied Products | 393 out of 2,075 | 81st |
Industry group Drugs | 304 out of 1,731 | 82nd |
Industry Pharmaceutical Preparations | 244 out of 1,333 | 82nd |
Source: SEC filing on March 21, 2018.
Ackermann's colleagues
We found four more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2017.
2017
William Humphries
Valeant Pharmaceuticals International
Group Chairman
2017
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2017
Thomas Appio
Valeant Pharmaceuticals International
Group Chairman
2017
Paul Herendeen
Valeant Pharmaceuticals International